International Journal of Nephrology

Peritoneal Dialysis–Moving from Current Status to the Future

Publishing date
21 Dec 2012
Submission deadline
03 Aug 2012

Lead Editor

1Division of Nephrology, Seoul National University Hospital, Seoul, South Korea

2Division of Nephrology, Kyungpook National University Hospital, Daegu, South Korea

3Division of Nephrology, University of Hong Kong, Pokfulam, Hong Kong

4Department of Medicine, McMaster University, Hamilton, ON Canada L8S4K1

Peritoneal Dialysis–Moving from Current Status to the Future


Peritoneal dialysis (PD) has been widely used as one of the major renal replacement therapies (RRT) for end-stage renal disease (ESRD) patients. Although PD therapy has witnessed remarkable technical advances, and the patient survival early after starting PD is comparable, or superior, to that of hemodialysis, it is currently faced with many challenges. Long-term PD is associated with progressive loss of UF capacity, resulting in increased cardiovascular morbidity or ultimate discontinuation of PD. This is related to the inflammation, new vessel formation (angiogenesis), and fibrotic thickening of the peritoneal membrane (PM). Bioincompatible PD fluid, along with peritonitis, is the major contributor to the PM change. PD has been relatively underutilized for acute renal failure (ARF) management or for the elderly. In order to establish PD as a more general and long-standing renal replacement therapy, clinicians and scientists need to investigate the pivotal issues such as adequate volume control and long-term preservation of the peritoneal membrane.

We are interested in the above-mentioned “contemporary issues of PD therapy” and encourage authors to submit original papers and review articles that could further impact an improvement in long-term outcomes of PD. Potential topics include, but are not limited to:

  • Fluid status assessment, Na removal, and adequate volume control
  • Dialysis adequacy and nutrition
  • Peritoneal immune system, inflammation, and adipokines
  • Issues related to ultrafiltration (UF) decrease or failure
  • Evidence of biocompatible peritoneal dialysis solutions
  • Outcomes of PD patients, including contributing factors and measures for improvement
  • Cardiovascular complications, pathophysiology, and outcomes
  • Mineral metabolism associated with peritoneal dialysis
  • Peritonitis and PD-related infections
  • Peritoneal dialysis for specific populations: elderly, children, and acute renal failure
  • QoL and psychosocial issues of PD
  • Epithelial-to-mesenchymal transition–pathogenetic mechanisms; new mediators and inhibitors
  • Mechanisms of peritoneal angiogenesis and fibrosis
  • Biomarkers and genetics pertaining to peritoneal membrane injury
  • Encapsulating peritoneal sclerosis–mechanisms, biomarkers, epidemiology, clinical issues, and therapy
  • RNA interference (including miRNA) and peritoneal membrane injury

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:


  • Special Issue
  • - Volume 2013
  • - Article ID 530713
  • - Editorial

Peritoneal Dialysis—Moving from Current Status to the Future

Kook-Hwan Oh | Yong-Lim Kim | ... | Peter J. Margetts
  • Special Issue
  • - Volume 2013
  • - Article ID 863791
  • - Clinical Study

Transperitoneal Calcium Balance in Anuric Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients

Chieko Hamada | Yasuhiko Tomino
  • Special Issue
  • - Volume 2013
  • - Article ID 263285
  • - Review Article

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Jesús Loureiro | Guadalupe Gónzalez-Mateo | ... | Abelardo Aguilera Peralta
  • Special Issue
  • - Volume 2013
  • - Article ID 940106
  • - Review Article

The Choice of Peritoneal Dialysis Catheter Implantation Technique by Nephrologists

T. Yip | S. L. Lui | W. K. Lo
  • Special Issue
  • - Volume 2013
  • - Article ID 424915
  • - Review Article

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients

Periklis Dousdampanis | Konstantina Trigka | Joanne M. Bargman
  • Special Issue
  • - Volume 2012
  • - Article ID 483250
  • - Review Article

Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis

Julia Kerschbaum | Paul König | Michael Rudnicki
  • Special Issue
  • - Volume 2012
  • - Article ID 812609
  • - Review Article

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes

Yeoungjee Cho | Sunil V. Badve | ... | David W. Johnson
  • Special Issue
  • - Volume 2012
  • - Article ID 239476
  • - Clinical Study

Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients

Aya Eguchi | Takahiro Mochizuki | ... | Ken Tsuchiya
International Journal of Nephrology
 Journal metrics
See full report
Acceptance rate30%
Submission to final decision80 days
Acceptance to publication21 days
Journal Citation Indicator0.510
Impact Factor-

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.